INSPライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (22 5月 2024 @ 01:57):

Stats
本日の出来高	345 067
平均出来高	581 877
時価総額	4.58B
EPS	$0 ( 2024-05-07 )
次の収益日	( $0 ) 2024-07-30
Last Dividend	$9.00 ( 2008-01-09 )
Next Dividend	$0 ( N/A )
P/E	-290.57
ATR14	$0.181 (0.12%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-10	Mccormick Shawn	Buy	2 500	Common Stock
2024-05-10	Mccormick Shawn	Sell	2 500	Stock Option (Right to Buy)
2024-05-02	Burks Cynthia	Buy	716	Common Stock
2024-05-02	Tansey Casey M	Buy	716	Common Stock
2024-05-02	Ellis Gary Lee	Buy	716	Common Stock

INSIDER POWER
5.08
Last 100 transactions
Buy: 146 836 \| Sell: 127 702

ボリューム相関

長: 0.09 (neutral)

短: 0.97 (very strong)

Signal:(44.273) Expect same movement, but be aware

Inspire Medical Systems 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Inspire Medical Systems 相関 - 通貨/商品

0.22
( neutral )

-0.17
( neutral )

-0.04
( neutral )

0.65
( weak )

-0.49
( neutral )

0.03
( neutral )

Inspire Medical Systems 財務諸表

Annual	2023
収益:	$624.80M
総利益:	$528.22M (84.54 %)
EPS:	$-0.720

FY	2023
収益:	$624.80M
総利益:	$528.22M (84.54 %)
EPS:	$-0.720

FY	2022
収益:	$407.86M
総利益:	$341.74M (83.79 %)
EPS:	$-1.600

FY	2021
収益:	$233.39M
総利益:	$200.12M (85.74 %)
EPS:	$-1.540

Financial Reports:

No articles found.

Inspire Medical Systems Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Inspire Medical Systems Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 7.27 - good (72.66%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	$9.00	2008-01-09
Last Dividend	$9.00	2008-01-09
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	$9.00	--
Avg. Dividend % Per Year	0.00%	--
Score	1.05	--
Div. Sustainability Score	7.27
Div.Growth Potential Score	0
Div. Directional Score	3.46	--

Next Divdend (Est)
(2024-05-21)

$0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

1.05

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2008	$0	0.00%
2009	$0	0.00%
2010	$0	0.00%
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend King	2023-06-30	Quarterly	2	5.23%	8.53
GOF	Dividend Royal	2023-11-14	Monthly	18	8.03%	8.50
VGI	Dividend Royal	2024-02-09	Monthly	13	7.36%	8.50
SRV	Dividend Royal	2023-12-04	Monthly	18	7.53%	8.50
PDI	Dividend Royal	2023-11-10	Monthly	13	7.86%	8.50
ORC	Dividend Royal	2023-11-29	Monthly	12	9.23%	8.50
JQC	Dividend Royal	2023-11-14	Monthly	22	6.56%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
MTR	Dividend Royal	2023-10-30	Monthly	39	10.10%	8.50
ZTR	Dividend King	2024-02-09	Monthly	37	8.35%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0238	1.500	-0.476	-0.714	[0 - 0.5]
returnOnAssetsTTM	-0.0229	1.200	-0.765	-0.918	[0 - 0.3]
returnOnEquityTTM	-0.0282	1.500	-1.424	-2.14	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	7.93	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	7.12	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	2.43	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.0357	-1.500	9.40	-10.00	[0 - 0.6]
interestCoverageTTM	-8.39	1.000	-4.22	-4.22	[3 - 30]
operatingCashFlowPerShareTTM	1.177	2.00	9.61	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.111	2.00	9.94	10.00	[0 - 20]
debtEquityRatioTTM	0.0416	-1.500	9.83	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.847	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	-0.0545	1.000	-3.09	-3.09	[0.1 - 0.6]
cashFlowToDebtRatioTTM	1.423	1.000	3.21	3.21	[0.2 - 2]
assetTurnoverTTM	0.964	0.800	6.91	5.53	[0.5 - 2]
Total Score				7.27

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-292.29	1.000	-10.00	0	[1 - 100]
returnOnEquityTTM	-0.0282	2.50	-0.915	-2.14	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.111	2.00	9.96	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	1.177	2.00	9.61	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-22.92	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0527	1.000	-1.181	0	[0.1 - 0.5]
Total Score				-0.347

Inspire Medical Systems Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Inspire Medical Systems

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.